Massachusetts Financial Services’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-99,111
| Closed | -$103K | – | 882 |
|
|
2024
Q3 | $103K | Sell |
99,111
-2,400
| -2% | -$2.5K | ﹤0.01% | 843 |
|
|
2024
Q2 | $176K | Buy |
101,511
+3,409
| +3% | +$5.9K | ﹤0.01% | 854 |
|
|
2024
Q1 | $234K | Sell |
98,102
-216
| -0.2% | -$516 | ﹤0.01% | 827 |
|
|
2023
Q4 | $327K | Sell |
98,318
-3,104
| -3% | -$10.3K | ﹤0.01% | 813 |
|
|
2023
Q3 | $379K | Sell |
101,422
-3,887
| -4% | -$14.5K | ﹤0.01% | 815 |
|
|
2023
Q2 | $450K | Sell |
105,309
-2,479
| -2% | -$10.6K | ﹤0.01% | 792 |
|
|
2023
Q1 | $737K | Sell |
107,788
-3,047
| -3% | -$20.8K | ﹤0.01% | 782 |
|
|
2022
Q4 | $878K | Buy |
110,835
+2,347
| +2% | +$18.6K | ﹤0.01% | 784 |
|
|
2022
Q3 | $1.04M | Sell |
108,488
-988
| -0.9% | -$9.5K | ﹤0.01% | 778 |
|
|
2022
Q2 | $793K | Buy |
109,476
+552
| +0.5% | +$4K | ﹤0.01% | 792 |
|
|
2022
Q1 | $1.41M | Buy |
108,924
+1,120
| +1% | +$14.5K | ﹤0.01% | 777 |
|
|
2021
Q4 | $1.72M | Sell |
107,804
-2,183
| -2% | -$34.9K | ﹤0.01% | 789 |
|
|
2021
Q3 | $1.77M | Sell |
109,987
-1,444
| -1% | -$23.2K | ﹤0.01% | 795 |
|
|
2021
Q2 | $1.54M | Buy |
111,431
+956
| +0.9% | +$13.2K | ﹤0.01% | 803 |
|
|
2021
Q1 | $1.61M | Sell |
110,475
-13,092
| -11% | -$191K | ﹤0.01% | 795 |
|
|
2020
Q4 | $2.15M | Sell |
123,567
-1,237
| -1% | -$21.5K | ﹤0.01% | 726 |
|
|
2020
Q3 | $2.29M | Sell |
124,804
-4,889
| -4% | -$89.7K | ﹤0.01% | 704 |
|
|
2020
Q2 | $2.32M | Sell |
129,693
-3,306
| -2% | -$59K | ﹤0.01% | 676 |
|
|
2020
Q1 | $2.16M | Buy |
132,999
+21,050
| +19% | +$341K | ﹤0.01% | 675 |
|
|
2019
Q4 | $2.02M | Buy |
111,949
+94,733
| +550% | +$1.71M | ﹤0.01% | 709 |
|
|
2019
Q3 | $349K | Buy |
+17,216
| New | +$349K | ﹤0.01% | 808 |
|